ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: cardiovascular disease

Physical Activity Reduces Risk of Rheumatoid Arthritis

Lara C. Pullen, PhD  |  October 31, 2019

A recent study has taken a more detailed look at the relationship between physical activity and the risk of developing rheumatoid arthritis (RA). Researchers found the more patients exercised weekly the lower their overall risk, specifically brisk and very brisk walking paces, along with longer cumulative average walking hours weekly were associated with a reduced risk for RA…

Filed under:ConditionsRheumatoid Arthritis Tagged with:physical activityRheumatoid Arthritis (RA)walking

Lightspring / shutterstock.com

Why You Should Consider Adding a Dietitian to Your Team

Linda Childers  |  October 18, 2019

A patient with rheumatoid arthritis (RA) asks if diet can help ease their symptoms. Or maybe a patient with severe knee osteoarthritis (OA) seeks diet advice because they want to lose weight and relieve pressure on their joints. Although there’s no specific nutrition plan for patients with rheumatic diseases, research has shown many dietary factors…

Filed under:Practice Support Tagged with:Association of Rheumatology Professionals (ARP)Dietdietitian

Clinical Insights into Gout Management: Rheumatology Drugs at a Glance Pt. 4

Mary Choy, PharmD, BCGP, FASHP  |  October 14, 2019

Three clinical experts on gout offer their insights into common management errors, clinical pearls, new safety data from the FDA and the role of biologic therapies in the management of gout.

Filed under:Biologics/DMARDsClinical Criteria/GuidelinesConditionsDrug UpdatesGout and Crystalline Arthritis Tagged with:GoutGout Resource Center

Mortality from Anti-neutrophil Cytoplasmic Autoantibody-Associated Vasculitis Falling Slightly

Will Boggs, MD  |  October 9, 2019

NEW YORK (Reuters Health)—Mortality rates in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis (AAV) decreased from 1999 to 2017, according to records from the Centers for Disease Control and Prevention (CDC). “The mortality attributed to several rare diseases [e.g., hypersensitivity pneumonitis] has increased in recent years,” Alexander W. Steinberg, MD, from Saint Joseph Hospital, Denver, tells…

Filed under:ConditionsVasculitis Tagged with:AAVGPAmortalitymortality rate

Rheumatology Drugs at a Glance, Part 3: Rheumatoid Arthritis

Mary Choy, PharmD, BCGP, FASHP  |  August 16, 2019

Over the past few years, bio­similars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options, others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and small molecule inhibitor drugs…

Filed under:ConditionsDrug UpdatesRheumatoid Arthritis Tagged with:abataceptadalimumabanakinrabaricitinibCertolizumab PegoletanerceptGolimumabinfliximabrituximabsarilumabtocilizumabTofacitinib

Ethics Forum: Beware Your Intellectual Conflicts of Interest

Evan Mulvihill, MD, MPH  |  July 18, 2019

A senior rheumatologist with extensive experience in the management of systemic lupus erythematosus is asked to help draft clinical guidelines for the treatment of lupus nephritis. Neither she nor her family members receive grant funding nor does she consult with any pharmaceutical or biotechnology companies. She does have strong clinical opinions based on current evidence…

Filed under:Ethics Tagged with:biasConflict of interestdisclosureEthics Forum

Dr. Sou-Pan Wu Is the First Recipient of the Norman B. Gaylis Research Award

Kimberly Retzlaff  |  May 29, 2019

The Norman B. Gaylis, MD, Research Award for Rheumatologists in Community Practice is designed to encourage practicing clinicians to conduct their own research for the betterment of patients and rheumatology. The 2019 inaugural honoree is Sou-Pan Wu, MD, who will research gout in the Hmong population in Minnesota…

Filed under:AwardsProfessional TopicsResearch Rheum Tagged with:AwardsGaylis AwardNorman B. Gaylis Research Award for Rheumatologists in Community PracticResearchRheumatology Research Foundation

Prevent Osteoporotic Fractures with a Fracture Liaison Service

Micah Yu, MD, Anna Lafian, DO, & Christina Downey, MD  |  May 18, 2019

Imagine leaving the hospital after suffering a heart attack without being treated for hypertension or being started on a beta blocker. What would we think of the hospital where patients are never educated about the relationship between treating hypertension and reducing myocardial infarction and stroke risk? Unfortunately, this happens every day with osteoporosis and fractures…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:FracturesOsteoporosisosteoporosis treatmentsosteoporotic fracture rates

New Study Examines Cerebrovascular Events in Lupus Patients

Linda Childers  |  May 17, 2019

Stroke and transient ischemia are the most common cerebrovascular events in lupus patients, and a new study has found most of these occurrences can be attributed to lupus itself rather than other causes. The study, published in the October 2018 issue of Arthritis Care & Research, looked at the frequency, association and outcomes of cerebrovascular…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:hemorrhagic strokeischemic strokestroke

Research Is Advancing Our Understanding of Gout & Hyperuricemia

Lara C. Pullen, PhD  |  March 19, 2019

CHICAGO—The Gout and Hyperuricemia scientific session at the 2018 ACR/ARHP Annual Meeting opened with a talk by Tony R. Merriman, PhD, a research professor at the University of Otago, New Zealand. His talk focused on molecular epidemiology, with an emphasis on the interactions between genes and environmental exposures, and their contributions to gout. Dr. Merriman…

Filed under:ConditionsGout and Crystalline ArthritisMeeting Reports Tagged with:2018 ACR/ARHP Annual MeetingGoutHuman Functional Genomics Projectshyperuricemia

  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 65
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences